The cumulative impact of RNA sequencing increases positive rate and decreases VUS rate
Learn MoreGround-breaking study shows low rates of germline testing in cancer patients especially among Asian, Black, and Hispanic patients.
Learn Moredemonstrates a 10% lower rate of VUS with WES/WGS compared to panels
Learn MoreOur comprehensive genetic testing menu includes screening and diagnosis for the following conditions:
No qualified patient should go without necessary testing due to cost.
4 OUT OF 5 PATIENTS PAY
AVERAGE COST FOR PATIENTS WHO DO PAY
(individual patient responsibility amounts may vary)With over 20 years of scientific innovations and discoveries, Ambry is an industry leader enabling healthcare professionals to confidently make informed care decisions with their patients by providing them with advanced genetic testing solutions.
At Ambry, people are at the center of our advancements, which starts with our own team. Recognized as an award-winning and outstanding place to work, we maintain a commitment to fostering diverse knowledge and perspectives to drive meaningful collaboration and help us all strive toward better health.